Home » Topics » BioWorld Science

BioWorld Science
RSS

NIH initiates phase III trial of antiretroviral regimens in pregnant women with HIV

Jan. 29, 2018

Novel compounds validate nicotinamide-N-methyltransferase as an antiobesity target

Jan. 29, 2018

RaQualia and ZTE Coming Biotech sign joint cooperation agreement

Jan. 29, 2018

EMA committee hands down negative opinion for enclomiphene MAA

Jan. 29, 2018

Novartis' branaplam given FDA orphan drug status for spinal muscular atrophy

Jan. 29, 2018

Bristol-Myers Squibb presents novel ROCK2 inhibitors

Jan. 29, 2018

Daewoong Pharmaceutical divulges new BTK inhibitors

Jan. 29, 2018

Blade Therapeutics identifies new calpain inhibitors

Jan. 29, 2018

Guangzhou Maxinovel Pharmaceuticals discloses PD-1 signaling inhibitors

Jan. 29, 2018

Acquist patents novel SLC22A12 inhibitors

Jan. 29, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...